Ignyta

Ignyta is a science-driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goal is to revolutionize the quality of biomarkers and tests available to rheumatologists and patients, helping them make more informed, personalized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to develop precise therapies for patients worldwide.